 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.7.1.20
- Adenosine kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
ATP + adenosine = ADP + AMP
|
 |
 |
 |
 |
 |
ATP
|
+
|
adenosine
Bound ligand (Het Group name = )
corresponds exactly
|
=
|
ADP
|
+
|
AMP
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Biological process
|
purine ribonucleoside salvage
|
1 term
|
 |
|
Biochemical function
|
nucleotide binding
|
6 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
|
Protein Sci
9:704-712
(2000)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of adenosine kinase from Toxoplasma gondii at 1.8 A resolution.
|
|
W.J.Cook,
L.J.DeLucas,
D.Chattopadhyay.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Human infection with Toxoplasma gondii is an important cause of morbidity and
mortality. Protozoan parasites such as T. gondii are incapable of de novo purine
biosynthesis and must acquire purines from their host, so the purine salvage
pathway offers a number of potential targets for antiparasitic chemotherapy. In
T. gondii tachyzoites, adenosine is the predominantly salvaged purine
nucleoside, and thus adenosine kinase is a key enzyme in the purine salvage
pathway of this parasite. The structure of T. gondii adenosine kinase was solved
using molecular replacement and refined by simulated annealing at 1.8 A
resolution to an R-factor of 0.214. The overall structure and the active site
geometry are similar to human adenosine kinase, although there are significant
differences. The T. gondii adenosine kinase has several unique features compared
to the human sequence, including a five-residue deletion in one of the four
linking segments between the two domains, which is probably responsible for a
major change in the orientation of the two domains with respect to each other.
These structural differences suggest the possibility of developing specific
inhibitors of the parasitic enzyme.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.Lüscher,
P.Onal,
A.M.Schweingruber,
and
P.Mäser
(2007).
Adenosine kinase of Trypanosoma brucei and its role in susceptibility to adenosine antimetabolites.
|
| |
Antimicrob Agents Chemother, 51,
3895-3901.
|
 |
|
|
|
|
 |
J.E.Hyde
(2007).
Targeting purine and pyrimidine metabolism in human apicomplexan parasites.
|
| |
Curr Drug Targets, 8,
31-47.
|
 |
|
|
|
|
 |
K.Lecoq,
I.Belloc,
C.Desgranges,
and
B.Daignan-Fornier
(2001).
Role of adenosine kinase in Saccharomyces cerevisiae: identification of the ADO1 gene and study of the mutant phenotypes.
|
| |
Yeast, 18,
335-342.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
|